{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O14656",
      "entity_text" : "ta",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The treatment with ta 600 mg/kg dose decreased the fasting blood glucose during the seventh day in diabetic mice while cholesterol and triglyceride levels decreased in the treated diabetic group, but glycogen and the expression of IRS-1, PI3-K, and AKT in the liver increased.",
  "reading_complete" : "2020-08-04T19:36:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T19:34:33Z",
  "trigger" : "decreased",
  "evidence" : [ "ta 600 mg/kg dose decreased the fasting blood glucose" ],
  "pmc_id" : "4768936",
  "score" : 0
}